Exogenous GM-CSF therapy for autoimmune pulmonary alveolar proteinosis: a systematic literature review

Exogenous GM-CSF therapy for autoimmune pulmonary alveolar proteinosis: a systematic literature review

BackgroundGranulocyte-macrophage colony-stimulating factor (GM-CSF) therapy is an important treatment for autoimmune pulmonary alveolar proteinosis (aPAP). Exogenous GM-CSF treatment can be administered either through subcutaneous injection or nebulized inhalation. However, data on the effectiveness...

Full description

Saved in:
Bibliographic Details
Main Authors: Wushu Chen, Xin Feng, Lun-kai Yao, Xingpei Li, Zhen-ming Yang, Xiu-yu Qin, Yu Li, Ye Qiu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Medicine
Subjects:
GM-CSF
aPAP
inhalation
subcutaneous injection
treatment dosage and duration
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1552566/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2025.1552566/full

Similar Items